Skip to main content

Table 8 Factors associated with quality of life of patients with breast cancer at Khartoum Oncology Hospital

From: Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital

Variables

QLQ-C30-Functional scales

S.E

Sig

OR

95% CI

Age

0.94

0.135

0.25

0.04–1.55

Comorbidity

0.44

0.355

0.67

0.28–1.58

Medications (ref. conventional therapy)

Hormonal therapy

0.53

0.01**

3.74

1.32–10.63

Targeted therapy

1.13

0.04*

10.2

1.11–93.88

Stage of tumor (ref. stage 1)

Stage 2

0.73

0.13

0.33

0.08–1.39

Stage 3

0.41

0.26

0.64

0.29–1.41

Cycle of chemotherapy

0.41

0.36

0.69

0.31–1.54

 

QLQ-C30-Symptom scales

Age

1.01

0.516

1.921

0.27–13.79

Comorbidity

0.46

0.863

0.924

0.38–2.26

Medications (ref. conventional therapy)

Hormonal therapy

0.67

0.000***

0.07

0.02–0.29

Targeted therapy

0.86

0.08

0.22

0.04–1.25

Stage of tumor (ref. stage 1)

Stage 2

0.85

0.14

3.52

0.67–18.61

Stage 3

0.39

0.76

1.13

0.53–2.42

Cycle of chemotherapy

0.40

0.87

0.94

0.43–2.05

  1. S.E Standard error, OR Odd ratio, CI Confidence interval
  2. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001